IP Library Granted Patent US 8,367,407
Granted Patent B2
US 8,367,407 · App. 12/409,587 · Granted Feb 5, 2013

Cells with altered fucosylation and producing antibodies therefrom

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,407
App. No.
12/409,587
Granted
Feb 5, 2013
Kind
B2
Abstract

The present invention relates to a cell and mammal in which GDP-mannose 4,6-dehydratase is knocked-out. The cell and mammal are useful for the production of an antibody molecule having high antibody-dependent cell-mediated cytotoxic activity, such as an antibody useful for treating various diseases. The cell and mammal are also useful for the production of a fragment of the antibody, and a fusion protein having the Fc region of the antibody.

Claims (16)

1. An isolated mammalian cell in which all the alleles of the genomic gene encoding GDP-mannose 4,6-dehydratase are knocked-out,

and wherein said knock-out of all the alleles of the genomic gene encoding GDP-mannose 4,6-dehydratase confers upon said mammalian cell resistance to a lectin which recognizes a complex N-glycoside-linked sugar chain structure comprising an N-acetylglucosamine at the reducing terminus, in which fucose is bound to the 6-position of the N-acetylglucosamine through an α-bond.

2. The isolated knock-out mammalian cell according to claim 1 , wherein said mammalian cell comprises an exogenous gene encoding a glycoprotein that comprises a complex N-glycoside-linked sugar chain.

3. The isolated cell according to claim 2 , wherein the glycoprotein produced by said mammalian cell does not contain a complex N-glycoside-linked sugar chain structure comprising an N-acetylglucosamine at the reducing terminus, in which fucose is bound to the 6-position of the N-acetylglucosamine through an α-bond.

4. The isolated knock-out mammalian cell according to claim 2 , wherein the glycoprotein is an antibody.

5. The isolated knock-out mammalian cell according to claim 4 , wherein the antibody belongs to an IgG class.

6. A process for producing a glycoprotein composition, which comprises culturing the isolated knock-out mammalian cell according to claim 2 in a medium to produce the glycoprotein in the resulting culture, and harvesting a composition comprising the glycoprotein from the culture.

7. The process according to claim 6 , wherein the glycoprotein is an antibody.

8. An isolated mouse cell in which all the alleles of the genomic gene encoding GDP-mannose 4,6-dehydratase are knocked-out,

wherein said knock-out of all the alleles of the genomic gene encoding GDP-mannose 4,6-dehydratase confers upon said cell resistance to a lectin which recognizes a complex N-glycoside-linked sugar chain structure comprising an N-acetylglucosamine at the reducing terminus, in which fucose is bound to the 6-position of the N-acetylglucosamine through an α-bond.

9. The isolated mouse cell according to claim 8 , wherein said mouse cell comprises an exogenous gene encoding a glycoprotein that comprises a complex N-glycoside-linked sugar chain.

10. The isolated mouse cell according to claim 9 , wherein the glycoprotein produced by said mouse cell does not contain a complex N-glycoside-linked sugar chain structure comprising an N-acetylglucosamine at the reducing terminus, in which fucose is bound to the 6-position of the N-acetylglucosamine through an α-bond.

11. The isolated mouse cell according to claim 10 , wherein the glycoprotein is an antibody.

12. The isolated mouse cell according to claim 11 , wherein the antibody belongs to an IgG class.

13. A process for producing a glycoprotein composition, which comprises culturing the isolated knock-out mouse cell according to claim 9 in a medium to produce the glycoprotein in the resulting culture, and harvesting a composition comprising the glycoprotein from the culture.

14. The process according to claim 13 , wherein the glycoprotein is an antibody.

Assignments (1)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →